(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to ...
Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE.
The Hearty Soul on MSN
High-Dose of Vitamin May Increase Bleeding Risk When Combined With Blood Thinners, Researchers Warn
High-dose vitamin E can amplify the vitamin blood thinners interaction, raising bleeding and hemorrhagic stroke risk. Learn the dose thresholds The post This Common Vitamin Could Be Dangerous If You ...
Larry Bordeaux, 65, has been on blood thinners since 2010, after he started developing deadly clots following an operation. He credits the drugs with saving his life. If he stops taking them for ...
Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns” in the road ahead, Bayer is confident that the course it’s laid out thus ...
(Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million (£20.70 million) to an Indiana couple over the drugmakers' failure to warn of ...
Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results